ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/11/29 | 2,200 | 2,245 | 2,065 | 2,110 | -122 | -5.5% | 5,075,600 |
2021/11/26 | 2,286 | 2,317 | 2,105 | 2,232 | +32 | +1.5% | 9,602,900 |
2021/11/25 | 2,300 | 2,418 | 2,158 | 2,200 | +77 | +3.6% | 22,453,500 |
2021/11/24 | 2,123 | 2,123 | 2,123 | 2,123 | +400 | +23.2% | 176,800 |
2021/11/22 | 1,707 | 1,724 | 1,680 | 1,723 | -2 | -0.1% | 450,600 |
2021/11/19 | 1,719 | 1,733 | 1,708 | 1,725 | +20 | +1.2% | 427,800 |
2021/11/18 | 1,721 | 1,738 | 1,700 | 1,705 | +3 | +0.2% | 576,200 |
2021/11/17 | 1,760 | 1,762 | 1,700 | 1,702 | -61 | -3.5% | 778,500 |
2021/11/16 | 1,741 | 1,811 | 1,741 | 1,763 | +23 | +1.3% | 657,300 |
2021/11/15 | 1,681 | 1,742 | 1,588 | 1,740 | -61 | -3.4% | 1,740,000 |
2021/11/12 | 1,800 | 1,838 | 1,746 | 1,801 | +103 | +6.1% | 1,152,700 |
2021/11/11 | 1,744 | 1,750 | 1,698 | 1,698 | -79 | -4.4% | 540,800 |
2021/11/10 | 1,754 | 1,781 | 1,752 | 1,777 | +18 | +1% | 226,800 |
2021/11/09 | 1,756 | 1,785 | 1,741 | 1,759 | +14 | +0.8% | 443,200 |
2021/11/08 | 1,760 | 1,783 | 1,745 | 1,745 | -22 | -1.2% | 399,700 |
2021/11/05 | 1,790 | 1,790 | 1,751 | 1,767 | -22 | -1.2% | 473,700 |
2021/11/04 | 1,830 | 1,839 | 1,787 | 1,789 | -21 | -1.2% | 399,800 |
2021/11/02 | 1,833 | 1,833 | 1,806 | 1,810 | -12 | -0.7% | 195,300 |
2021/11/01 | 1,830 | 1,840 | 1,804 | 1,822 | +5 | +0.3% | 293,600 |
2021/10/29 | 1,841 | 1,848 | 1,803 | 1,817 | -1 | -0.1% | 249,200 |
2021/10/28 | 1,835 | 1,841 | 1,808 | 1,818 | -25 | -1.4% | 326,900 |
2021/10/27 | 1,880 | 1,881 | 1,830 | 1,843 | -47 | -2.5% | 389,700 |
2021/10/26 | 1,885 | 1,904 | 1,870 | 1,890 | +32 | +1.7% | 277,600 |
2021/10/25 | 1,857 | 1,872 | 1,835 | 1,858 | -19 | -1% | 296,100 |
2021/10/22 | 1,876 | 1,894 | 1,865 | 1,877 | +3 | +0.2% | 270,300 |
2021/10/21 | 1,910 | 1,914 | 1,865 | 1,874 | -44 | -2.3% | 423,100 |
2021/10/20 | 1,930 | 1,948 | 1,906 | 1,918 | +8 | +0.4% | 354,300 |
2021/10/19 | 1,911 | 1,921 | 1,886 | 1,910 | +14 | +0.7% | 240,100 |
2021/10/18 | 1,949 | 1,953 | 1,889 | 1,896 | -48 | -2.5% | 428,100 |
2021/10/15 | 1,956 | 1,956 | 1,914 | 1,944 | +9 | +0.5% | 241,600 |
2021/10/14 | 1,941 | 1,953 | 1,923 | 1,935 | +9 | +0.5% | 295,900 |
2021/10/13 | 1,939 | 1,955 | 1,922 | 1,926 | -18 | -0.9% | 273,300 |
2021/10/12 | 1,996 | 2,005 | 1,942 | 1,944 | -45 | -2.3% | 480,200 |
2021/10/11 | 1,972 | 1,995 | 1,943 | 1,989 | +12 | +0.6% | 486,900 |
2021/10/08 | 1,955 | 2,003 | 1,952 | 1,977 | +34 | +1.7% | 724,700 |
2021/10/07 | 1,887 | 1,955 | 1,882 | 1,943 | +87 | +4.7% | 765,600 |
2021/10/06 | 1,905 | 1,911 | 1,839 | 1,856 | -26 | -1.4% | 519,900 |
2021/10/05 | 1,880 | 1,909 | 1,834 | 1,882 | -27 | -1.4% | 848,600 |
2021/10/04 | 1,965 | 1,992 | 1,897 | 1,909 | -27 | -1.4% | 739,100 |
2021/10/01 | 1,920 | 1,947 | 1,904 | 1,936 | +31 | +1.6% | 577,600 |
2021/09/30 | 1,892 | 1,928 | 1,878 | 1,905 | +23 | +1.2% | 537,000 |
2021/09/29 | 1,860 | 1,892 | 1,843 | 1,882 | -15 | -0.8% | 548,100 |
2021/09/28 | 1,942 | 1,949 | 1,876 | 1,897 | -61 | -3.1% | 751,800 |
2021/09/27 | 1,992 | 1,997 | 1,950 | 1,958 | -30 | -1.5% | 435,800 |
2021/09/24 | 1,993 | 2,018 | 1,984 | 1,988 | +35 | +1.8% | 615,400 |
2021/09/22 | 1,985 | 2,000 | 1,938 | 1,953 | -33 | -1.7% | 666,800 |
2021/09/21 | 1,960 | 2,003 | 1,946 | 1,986 | -36 | -1.8% | 695,800 |
2021/09/17 | 1,979 | 2,025 | 1,965 | 2,022 | +43 | +2.2% | 587,300 |
2021/09/16 | 2,021 | 2,039 | 1,937 | 1,979 | -70 | -3.4% | 1,157,400 |
2021/09/15 | 1,960 | 2,082 | 1,944 | 2,049 | +76 | +3.9% | 1,673,700 |
701~
750
件表示中 / 4944件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 246,000円 | +7.6% | +57.5% | 2.15% | 19.02倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム